Table of Contents 2
List of Tables 4
List of Figures 4
ContraFect Corporation Snapshot 5
ContraFect Corporation Overview 5
Key Information 5
Key Facts 5
ContraFect Corporation - Research and Development Overview 6
Key Therapeutic Areas 6
ContraFect Corporation - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
ContraFect Corporation - Pipeline Products Glance 11
ContraFect Corporation - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
ContraFect Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
ContraFect Corporation - Drug Profiles 14
CF-301 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CF-401 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CF-402 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CF-403 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CF-404 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Monoclonal Antibody 1 for Influenza 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CF-302 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
CF-303 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
CF-304 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
CF-305 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
CF-306 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CF-307 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
CF-308 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
CF-309 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
ContraFect Corporation - Pipeline Analysis 29
ContraFect Corporation - Pipeline Products by Target 29
ContraFect Corporation - Pipeline Products by Route of Administration 30
ContraFect Corporation - Pipeline Products by Molecule Type 31
ContraFect Corporation - Pipeline Products by Mechanism of Action 32
ContraFect Corporation - Recent Pipeline Updates 33
ContraFect Corporation - Dormant Projects 36
ContraFect Corporation - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39